Company
Plexium
Delivering Transformative Precision Medicines for Patients in Need
Also known as PLEXIUM, INC.
- Headquarters
- San Diego, CA, United States
- Legal name
- PLEXIUM, INC.
Claim, correct or request removal
Record updated 28 September 2026
About
Plexium is the premier, next-generation targeted protein degradation (TPD) company. We lead the way in the rational design and discovery of Monovalent Direct Degraders and Molecular Glues. Our small molecule compounds are being developed as potential first-in-class and best-in-class treatments for high unmet medical needs.
Funding snapshot
- Total raised
- $60.1MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $60.1M2025-07-14
Funding rounds
- Round, 2025
- $60.1M2025-07-14, SEC form D sold, 20 investors
Products
- Web
- DELTA Discovery™
Loading relationship preview